Compare Pinterest Inc (PINS) vs Sanofi SA (SNY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Pinterest Inc vs Sanofi SA — how do they compare? Pinterest Inc trades at $21.4 (market cap $11.63B), while Sanofi SA trades at $40.07 (market cap $95.18B). The key difference: Sanofi SA is far larger — about 8.2× Pinterest Inc's market cap, and Sanofi SA pays a 6.01% dividend while Pinterest Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Pinterest Inc for 85 Days and Sanofi SA for 94 Days on average.
| PINS | SNY | |
|---|---|---|
Market Cap | $11.63B | $95.18B |
Volume | 12,792,940 | 2,995,646 |
Sector | Media | Health |
52-Week High | $35.24 | $52.34 |
52-Week Low | $15.42 | $39.51 |
Typical Hold Time | 85 Days | 94 Days |
Enterprise Value | $11.55B | $114.48B |
Dividend Yield | — | 6.01% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Pinterest (PINS) trades at $21.40, up 5.37% with bullish technical signals despite mixed oscillators. The company shows strong revenue growth from $2.8B in 2022 to $4.2B in 2025, with recent earnings beats and a 79.5% gross margin. Analyst consensus is bullish with a $27.93 price target, though high P/E of 60.4 and insider selling pose valuation concerns.
Outlook remains positive driven by international monetization and new ad products, but risks include competitive pressure and reliance on advertising revenue. The stock offers growth potential if execution continues, though current valuation demands careful monitoring of earnings sustainability.
Sanofi (SNY) trades at $40.07, down 0.32% on the day, with a bearish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $1.21 exceeding the $1.10 estimate. Revenue for 2025 reached $46.72 billion, with a net income margin of 16.72%. Recent news highlights a significant $8 billion immunology alliance expansion with Regeneron, signaling strategic growth initiatives.
The outlook is mixed; solid profitability and a strategic partnership provide upside potential, but a projected net income decline to $4.0 billion in 2026 and bearish technical indicators pose risks. Analyst sentiment is cautiously optimistic with a 44% buy rating, though investors should monitor execution of new collaborations and patent expiration impacts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Pinterest Inc
Pinterest is an online product and idea discovery platform that helps users gather ideas on everything from recipes to cook to destinations to travel to. Founded in 2010, the platform consists of a largely female audience, at roughly two thirds of its more than 365 million monthly active users. The company generates revenue by selling digital ads and is now rolling out more in-platform e-commerce features.
Read more on PINS →About Sanofi SA
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →
